← Browse by Condition
Medical Condition
schizophrenia disorders
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06674694 Phase 1
Recruiting
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
Enrollment
56 pts
Location
China
Sponsor
Sichuan Kelun Pharmaceutical R...
NCT06939088 Phase 2
Recruiting
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Enrollment
108 pts
Location
Denmark
Sponsor
Anders Fink-Jensen, MD, DMSci